Media Archive
Eczema Treatment Cuts Risk of Death From COVID-19
A monoclonal antibody used to treat asthma and eczema can improve survival for patients with moderate to severe COVID-19, a clinical trial at UVA Health suggests.
Powerful Computer Models ID Weaknesses in Deadly C. difficile
The researchers say their new work represents a significant step forward in the use of a form of predictive computer modeling called GENREs to battle infectious diseases.
Innovator of the Year Made Herculean Efforts Throughout the Pandemic
At the beginning of the pandemic, when federal health agencies couldn’t provide enough COVID-19 tests, Mathers worked with Melinda Poulter to help create in-house tests to meet the demand at UVA and at hospitals across the state.
“When lenacapavir is used for
treatment in people living with HIV,
it has to be given in combination
with other drugs. If a person
stops taking treatment, the virus
will return. Lenacapavir is also
not a vaccine. If a person using
lenacapavir for PrEP stops getting
doses, they can be at risk for
acquiring HIV.” Jackson said
READ MORE
Bird flu cases are on the rise
with a possible human-to-human
transmitted case, and confirmed
first case in a child in California,
increasing the concerns of a wider
outbreak.
However, infectious disease expert
Dr. Patrick Jackson with UVA Health
said while the disease is evolving
and becoming more transmissible,
it is not time panic.
WATCH VIDEO
Baby taking droplet vaccine to prevent rotavirus.
University of Virginia researchers are developing a flexible online tool for navigating information used in the fight to save children from deadly diarrheal diseases by identifying transmission hotspots and accelerating the deployment of treatments and new vaccines.
“What I really love is the translational work we’re doing and knowing the ability of our work can directly impact to the public health.”
“Our work impacts human health for Virginians and for communities globally, such as those with whom we deeply collaborate in Tanzania, Uganda, and Bangladesh.
To better understand E. coli and its impact on human health, UVA Today reached out to Melissa Kendall, PhD, an associate professor in the Department of Microbiology, Immunology and Cancer Biology, and William Petri, MD, PhD, the Wade Hampton Frost Professor of Medicine, to get their insights into the outbreak.